🇺🇸 LQDA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Liquidia Corporation
🇺🇸 A court finding that Yutrepia infringed two valid claims of United Therapeutics’ ‘327 patent has put the drug’s PH-ILD indication and broader availability at risk. SueWallSt notifies investors of a pending investigation into potential securities law violations on behalf of Liquidia… Source: prnewswire Country: United States